Ginkgo Bioworks Holdings Inc (DNA)
7.72
-0.88
(-10.23%)
USD |
NYSE |
Nov 14, 11:01
Ginkgo Bioworks Holdings Market Cap: 429.04M for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 477.95M |
| November 12, 2024 | 466.28M |
| November 11, 2024 | 486.84M |
| November 08, 2024 | 471.84M |
| November 07, 2024 | 465.72M |
| November 06, 2024 | 461.83M |
| November 05, 2024 | 444.05M |
| November 04, 2024 | 424.04M |
| November 01, 2024 | 430.71M |
| October 31, 2024 | 423.48M |
| October 30, 2024 | 435.71M |
| October 29, 2024 | 445.16M |
| October 28, 2024 | 459.61M |
| October 25, 2024 | 453.50M |
| October 24, 2024 | 441.27M |
| October 23, 2024 | 502.96M |
| October 22, 2024 | 521.30M |
| October 21, 2024 | 495.73M |
| October 18, 2024 | 493.51M |
| October 17, 2024 | 465.72M |
| October 16, 2024 | 459.61M |
| October 15, 2024 | 432.93M |
| October 14, 2024 | 404.59M |
| October 11, 2024 | 407.37M |
| October 10, 2024 | 399.03M |
| Date | Value |
|---|---|
| October 09, 2024 | 439.60M |
| October 08, 2024 | 463.50M |
| October 07, 2024 | 464.61M |
| October 04, 2024 | 462.94M |
| October 03, 2024 | 451.27M |
| October 02, 2024 | 428.49M |
| October 01, 2024 | 422.37M |
| September 30, 2024 | 452.94M |
| September 27, 2024 | 449.60M |
| September 26, 2024 | 427.93M |
| September 25, 2024 | 431.27M |
| September 24, 2024 | 448.49M |
| September 23, 2024 | 435.16M |
| September 20, 2024 | 445.16M |
| September 19, 2024 | 461.83M |
| September 18, 2024 | 411.81M |
| September 17, 2024 | 378.47M |
| September 16, 2024 | 346.23M |
| September 13, 2024 | 351.24M |
| September 12, 2024 | 348.46M |
| September 11, 2024 | 346.79M |
| September 10, 2024 | 326.78M |
| September 09, 2024 | 297.88M |
| September 06, 2024 | 314.00M |
| September 05, 2024 | 341.23M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
297.88M
Minimum
Sep 09 2024
788.86B
Maximum
Sep 27 2021
13.01B
Average
3.566B
Median
Dec 05 2022
Market Cap Benchmarks
| Boston Scientific Corp | 130.64B |
| UnitedHealth Group Inc | 551.24B |
| CEL-SCI Corp | 36.28M |
| AIM ImmunoTech Inc | 15.70M |
| IGC Pharma Inc | 27.46M |
Market Cap Related Metrics
| PS Ratio | 2.091 |
| Price to Book Value | 0.5150 |
| Price | 7.72 |
| Earnings Yield | -238.3% |